Cuál es el precio por Amphastar Pharmaceuticals, Inc. (AMPH)

Precio por Amphastar Pharmaceuticals, Inc. (AMPH) es de$22.00

Cuál es la capitalización de mercado por Amphastar Pharmaceuticals, Inc. (AMPH)

Capitalización de mercado por Amphastar Pharmaceuticals, Inc. (AMPH) es $970.00M

Amphastar Pharmaceuticals, Inc. (AMPH) Historial de Precios

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.

Año	Rendimiento
2026 (TTM)	-11.84%
2025	-35.78%
2024	-30.46%
2023	106.09%
2022	32.04%
2021	15.64%
2020	-2.11%
2019	-6.67%
2018	8.09%
2017	-3.87%
2016	37.35%
2015	23.57%
2014	0.00%

Año

Rendimiento

2026 (TTM)

-11.84%

2025

-35.78%

2024

-30.46%

2023

106.09%

2022

32.04%

2021

15.64%

2020

-2.11%

2019

-6.67%

2018

8.09%

2017

-3.87%

2016

37.35%

2015

23.57%

2014

0.00%

Empresa	Precio de la acción	Cambio 1a%	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$166.36	31.46%	DE
Takeda Pharmaceutical Company Limited 4502.T	$37.84	25.87%	JP
Galderma Group AG GALD.SW	$222.33	27.49%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$21.19	17.16%	IN

Empresa

Precio de la acción

Cambio 1a%

País